Herbalife Q3 net sales up 6.0% to $1.35 billion; full-year sales guidance raised
Herbalife reported third-quarter 2026 net sales of $1.35 billion, up 6.0% from a year earlier, and diluted EPS of $0.55 versus $0.42. The company raised its full-year 2026 net sales guidance and maintained its reported adjusted EBITDA guidance, while announcing a new $250 million share repurchase program and a leadership change, with John DeSimone named interim CEO and Scott Schaefer named CFO, both effective November 1, 2026.
Key points
- Q3 net sales of $1.35 billion, up 6.0% year over year (7.6% at constant currency); net income attributable to Herbalife of $58.8 million vs. $43.2 million a year earlier
- Diluted EPS of $0.55 vs. $0.42; adjusted diluted EPS of $0.64 vs. $0.50
- Full-year 2026 net sales guidance increased on reported and constant currency bases; adjusted EBITDA guidance maintained on a reported basis
- Board authorized a share repurchase program of up to $250 million over three years; no shares were repurchased in Q3; John DeSimone named interim CEO
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 02, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.